Skip to Main Content

Author Details

Helong Zhao
Versiti Blood Research Institute and Medical College of Wisconsin
2012
22
12
PMIDPaper TitleJournal TitlePublished Year
36947811Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions.Blood2023
33969603Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4.Mol Oncol2022
35961320Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling.Neuron2022
35951346CSF3R and SETBP1 getting high on LSD1.Blood2022
34780648MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.Blood2022
33513367Eradicating residual chronic myeloid leukaemia: basic research lost in translation.Lancet Haematol2021
32908250Declaration of Bcr-Abl1 independence.Leukemia2020
32999432Imatinib is not a potent anti-SARS-CoV-2 drug.Leukemia2020
28001501The small GTPase ARF6 regulates protein trafficking to control cellular function during development and in disease.Small GTPases2019
28812582Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism.Nat Cell Biol2017
29058688Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.J Clin Invest2017
26778715Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis.Mol Oncol2016
27603130Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation.Nat Med2016
25572331RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.Cancer Res2015
26573004Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.Mol Cancer2015
25660577Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.Mol Oncol2015
25622979miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.Mol Cancer2015
25779666Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.Oncotarget2015
24272999Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia.J Immunol2014
24886617C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.Breast Cancer Res2014
23294842N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.Retrovirology2013
22323535The adaptor protein SLP-76 regulates HIV-1 release and cell-to-cell transmission in T cells.J Immunol2012
  • 1 - 22 of 22

Recommended Authors

Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 6
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
University Hospital Luebeck
Career Start Year 2012
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Nottingham Trent University
Career Start Year 2010
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
University of California irvine
Career Start Year 2009
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Shanghai General Hospital, Shanghai Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Institute of Anatomy, Technische Universitat Dresden School of Medicine
Career Start Year 2001
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 2
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0

Collaborators

University of Utah Huntsman Cancer Institute
Co-authored papers 6
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 1
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
University of Utah
Co-authored papers 1
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Huntsman Cancer Institute
Co-authored papers 1
University of Washington
Co-authored papers 1
The University of Utah
Co-authored papers 1
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
University of Utah
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Inner Mongolia University
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 1
Fred Hutchinson Cancer Center
Co-authored papers 1
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 1
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Fred Hutchinson Cancer Center
Co-authored papers 1
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Institute of Cancer Research
Co-authored papers 1
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Texas Tech University Health Sciences Center at El Paso
Co-authored papers 1
Fred Hutchinson Cancer Center.
Co-authored papers 1
Oregon Health & Science University School of Medicine
Co-authored papers 1
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Huntsman Cancer Institute
Co-authored papers 1